Knowledge (XXG)

Gevotroline

Source ๐Ÿ“

Chemical compound
Gevotroline
Clinical data
Routes of
administration
Oral
ATC code
  • None
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • 8-fluoro-2-(3-pyridin-3-ylpropyl)-1,3,4,5-tetrahydropyridoindole
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H20FN3
Molar mass309.388 gยทmol
3D model (JSmol)
  • Fc2cc1c3c(c1cc2)CCN(C3)CCCc4cccnc4

Gevotroline (WY-47,384) is an atypical antipsychotic with a tricyclic structure which was under development for the treatment of schizophrenia by Wyeth-Ayerst. It acts as a balanced, modest affinity D2 and 5-HT2 receptor antagonist and also possesses high affinity for the sigma receptor. It was well tolerated and showed efficacy in phase II clinical trials but was never marketed.

See also

References

  1. Triggle DJ (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
  2. ^ Abou-Gharbia M, Moyer JA (1990). Bristol JA (ed.). "Novel Antipyschotic Agents". Annual Reports in Medicinal Chemistry. 25. Boston: Academic Press: 1โ€“10. doi:10.1016/S0065-7743(08)61577-8. ISBN 0-12-040525-3.
  3. ^ Jackson DM, Mohell N (1996). "A Review of the Pharmacology of New Antipsychotic Drugs". In Stone TW (ed.). CNS neurotransmitters and neuromodulators: dopamine. Boca Raton: CRC Press. ISBN 0-8493-7632-7.
  4. Snyder SH, Largent BL (1989). "Receptor mechanisms in antipsychotic drug action: focus on sigma receptors". The Journal of Neuropsychiatry and Clinical Neurosciences. 1 (1): 7โ€“15. doi:10.1176/jnp.1.1.7. PMID 2577720.
  5. Matheson GK, Guthrie D, Bauer C, Knowles A, White G, Ruston C (January 1991). "Sigma receptor ligands alter concentrations of corticosterone in plasma in the rat". Neuropharmacology. 30 (1): 79โ€“87. doi:10.1016/0028-3908(91)90046-E. PMID 1675451. S2CID 29702968.
  6. Gudelsky GA, Nash JF (February 1992). "Neuroendocrinological and neurochemical effects of sigma ligands". Neuropharmacology. 31 (2): 157โ€“162. doi:10.1016/0028-3908(92)90026-L. PMID 1348112. S2CID 36585024.
Typical
Disputed
Atypical
Others
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT3โ€“7
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
ฯƒ1
ฯƒ2
Unsorted
Classes
Antidepressants
(Tricyclic antidepressants (TCAs))
Antihistamines
Antipsychotics
Anticonvulsants
Anticholinergics
Others

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

โ†‘